Newsroom

CAMBRIDGE, England--(BUSINESS WIRE)--Constructive Bio’s founder and Chief Scientific Officer, Professor Jason Chin, has been named the recipient of the 2026 Heinrich Wieland Prize, one of Europe’s most prestigious honours for fundamental research in the life sciences. The award places Professor Chin among past laureates, including five Nobel Prize winners, and recognises the genetic-code-expansion technology now being applied to next-generation therapeutics, including GLP-1s. The award, present...

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of Carolyn Starrett to its Board of Directors....

PLANO, Texas--(BUSINESS WIRE)--ZIPS Car Wash is launching its summer “Red, White & Shine” celebration, a seasonal promotion during peak summer travel, including road trips, lake visits, and all those celebrating America’s 250th Anniversary. ZIPS is offering customers 25% off the Best Wash package at participating locations nationwide. The limited time offer runs from June 23–July 12, 2026, using promo code USA. “We want to help Americans keep their vehicles clean and protected through every...

LONDON--(BUSINESS WIRE)--  24-June-2026 Issue: Mitsubishi HC Capital UK Plc Series 881 XS2901976279 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 27-March-2026 Date To: 29-June-2026 Record Date: 24-June-2026 Value Date: 29-June-2026 Benchmark Rate: 0.74108% Margin: 0.46% Total Rate: 1.20108% Floor: 0% Number of Days: 94 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Total Amount Due: JPY...

MONTRÉAL--(BUSINESS WIRE)--FlightHubMD, agence de voyages en ligne canadienne de premier plan, élargit son écosystème avec le lancement de FlightHub Hôtels, permettant désormais aux voyageurs de réserver leurs vols, hôtels et forfaits vacances sur une seule et même plateforme. Cette nouvelle offre, qui donne accès à plus de 2,6 millions d’options d’hébergement à travers le monde,marque une étape majeure dans l’évolution de FlightHub en tant que guichet unique de la planification de voyages. Afi...

CHICAGO--(BUSINESS WIRE)--Fingerprint, a leader in device intelligence, today announced that FingerprintJS, the world’s most popular open-source browser fingerprinting library, has officially surpassed 1 million weekly downloads. This major milestone underscores the project’s widespread adoption as the open-source industry standard for browser fingerprinting. FingerprintJS enables developers to identify browser sessions with high accuracy, helping them prevent fraud, manage account security, an...

GAND, Belgique--(BUSINESS WIRE)--MRM Health, société de biotechnologie en phase clinique développant des thérapies basées sur le microbiome pour les maladies à médiation immunitaire, annonce aujourd’hui la nomination à son Conseil d’administration de deux dirigeants expérimentés du secteur, à un moment clé de son développement. Avec son programme phare MH002 actuellement en phase 2b de développement clinique, l’obtention récente de la désignation FDA Fast Track et un financement de Série B de 5...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study of botensilimab (BOT), an Fc-enhanced multifunctional anti–CTLA-4 antibody, plus balstilimab (BAL), an anti–PD-1 antibody, in patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases will be presented at the European Society for Medical Oncology Gastrointestinal C...

CLEARWATER, Fla. & FREMONT, Calif.--(BUSINESS WIRE)--TD SYNNEX (NYSE: SNX) today announced financial results for the fiscal second quarter ended May 31, 2026. Consolidated Financial Highlights for the Fiscal 2026 Second Quarter GAAP ($ in millions, except earnings per share)                 Q2 FY26   Q2 FY25   Net Change from Q2 FY25 Revenue   $ 19,575     $ 14,946     31.0 % Gross profit   $ 1,339     $ 1,046     28.0 % Gross margin     6.84 %     7.00 %   (16) bps Operating income   $ 519    ...

GHENT, Belgium--(BUSINESS WIRE)--MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors as the Company enters a pivotal phase of growth. With its lead program, MH002, in Phase 2b clinical development, recent FDA Fast Track designation and a €55 million Series B financing, MRM Health is strengthening its Board to support the Company through its next clin...